Clinical Trial Update: Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP) [Phase 4]

View source ↗

Summary

This clinical trial update reports results from a Phase 4 study evaluating Truvada plus raltegravir for nonoccupational post-exposure prophylaxis (nPEP) in HIV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2016-02-08